How brain stimulation repairs the depressed brain

By Elodie Vaz | Published on May 21, 2026 | 4 min read


Depression remains one of the major challenges of contemporary psychiatry. Despite the proven effectiveness of certain treatments, the precise biological mechanisms that allow the brain to recover from a depressive state remain largely unclear. A team from UCLA Health now claims to have reached a major milestone. In a study published on May 7 in Cell, researchers describe for the first time how an accelerated form of transcranial magnetic stimulation (TMS) physically repairs brain circuits altered by stress, paving the way for a mechanistic understanding of the antidepressant effects of this therapy.

Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive technique approved by the FDA, primarily used in patients suffering from treatment-resistant depression. It relies on the application of electromagnetic pulses through a coil placed on the scalp in order to modulate the activity of targeted brain regions, particularly the prefrontal cortex. However, while the clinical benefits of the method have been known for several years, its action at the cellular level has until now remained a “black box.”

Finally understanding how TMS works

The objective of the UCLA-led study was precisely to decipher the neuronal mechanisms responsible for the rapid effects observed with a new generation of protocols: accelerated intermittent theta burst stimulation (aiTBS). Unlike traditional protocols requiring six weeks of daily sessions, this approach condenses treatment into just five days and often provides rapid relief from depressive symptoms.

The study was co-led by Dr. Scott Wilke and Dr. Laura DeNardo. According to Dr. Wilke, this research marks a turning point. “This work allows us to bridge our clinical observations with the cellular-level insights that only cutting-edge neuroscience tools can provide. For the first time, we can precisely observe which brain cells are modified by this rapid treatment and how this restoration promotes recovery from depression-related behaviors.”

To study the biological effects of aiTBS, the researchers developed, in collaboration with the National Institutes of Health, an experimental model reproducing the protocols used in human clinical practice. Mice subjected to chronic stress in order to mimic certain features of depression were stimulated while awake, while their brain activity was observed in real time.

The researchers focused particularly on dendritic spines, tiny structures essential for synaptic communication between neurons. They observed that chronic stress caused a significant loss of these structures in the prefrontal cortex, a key region involved in regulating emotions and adaptive behaviors.

Targeted restoration of neural circuits

The study’s major finding lies in the highly selective nature of the stimulation’s effects. Just one day of aiTBS was enough to restore lost synaptic connections, but only in a specific subtype of neurons: intratelencephalic (IT) neurons. Neighboring neuronal populations remained largely unchanged.

Professor Michael Gongwer emphasized the researchers’ surprise: “We initially thought that transcranial magnetic stimulation would broadly affect the prefrontal cortex, but its effects turned out to be remarkably precise. Observing the reappearance of lost synaptic structures, and then seeing those same neurons regain activity during behavior, was incredibly exciting.”

The experiments also showed that when the activity of IT neurons is blocked during stimulation, the antidepressant effects disappear completely. According to Dr. DeNardo, this demonstrates that these neurons play a central role in behavioral recovery. “Stress disrupts the structural scaffolding that neurons rely on to communicate. By restoring these structures in IT neurons, stimulation reactivates the circuits that support adaptive behaviors.”

Behavioral benefits were observed within 24 hours following treatment and persisted for at least one week after a single day of stimulation. According to Dr. Wilke, this persistence is essential. “What is striking is that this is not simply a temporary modification of activity. The treatment restores neuronal structure in a way that enables the recovery of normal circuit function and normal behavior.”

Toward precision neuromodulation

Although the authors emphasize that animal models cannot reproduce the full complexity of human depression, this study provides one of the most compelling demonstrations to date of the link between brain stimulation, synaptic repair, and behavioral improvement.

Beyond depression, TMS is already being used in several disorders associated with dysfunctions in specific neural circuits, including OCD, chronic pain, PTSD, and tinnitus. This work could therefore accelerate the emergence of personalized neuromodulation. As Dr. Wilke summarizes: “Every patient is unique. By studying these treatments in mice, we can systematically test how different stimulation parameters modify brain circuits, which could ultimately help us tailor neuromodulation therapies to each patient.”



                  Read next: Optimism: an unexpected protective factor against dementia




About the Author – Elodie Vaz
Health journalist, CFPJ graduate (2023).
Élodie explores the marks diseases leave on bodies and, more broadly, on human life. A registered nurse since 2010, she spent twelve years at patients’ bedsides before exchanging her stethoscope for a notebook. She now investigates the links between environment and health, convinced that the vitality of life cannot be reduced to that of humans.